HDAC4 Brachydactyly-Mental Retardation Syndrome — designated BDMR, also known as HDAC4 Haploinsufficiency Syndrome, 2q37 Deletion Syndrome, and Albright Hereditary Osteodystrophy-like Syndrome (AHO-like), OMIM #600430, an autosomal dominant neurodevelopmental syndrome estimated to affect approximately 1 in 100,000 individuals with several hundred to low thousands of diagnosed cases worldwide, caused by heterozygous loss-of-function pathogenic variants in HDAC4 (histone deacetylase 4 gene, chromosome 2q37.3) or by chromosomal deletion of 2q37 encompassing HDAC4 — representing a clinically important distinction because isolated HDAC4 intragenic mutations produce a phenotype attributable entirely to HDAC4 haploinsufficiency while 2q37 chromosomal deletions of variable size may encompass neighboring genes whose haploinsufficiency contributes additional phenotypic features, making molecular characterization of the deletion boundary a clinically relevant detail that affects prognosis and multi-system surveillance planning; HDAC4 encodes a class IIa histone deacetylase, a member of the zinc-dependent histone deacetylase enzyme family that removes acetyl groups from histone lysine residues, with HDAC4 being unique among class IIa deacetylases in its dual nucleocytoplasmic shuttling behavior — HDAC4 resides in the cytoplasm in phosphorylated form but translocates to the nucleus in response to calcium signaling and MEF2 (myocyte enhancer factor 2) transcription factor binding, where it represses gene expression by deacetylating histone tails and recruiting co-repressors including NCoR and SMRT; HDAC4 has a particularly critical and cell-type-specific role in chondrocyte differentiation and endochondral bone formation — HDAC4 functions as a repressor of RUNX2 (runt-related transcription factor 2, the master regulator of osteoblast differentiation and endochondral ossification), maintaining RUNX2 in a transcriptionally inactive state in proliferating chondrocytes; when HDAC4 is absent or haploinsufficient, RUNX2 is derepressed prematurely, causing premature chondrocyte differentiation and premature ossification of the growth plate, resulting in brachydactyly — specifically brachymetaphalangia of the 4th and 5th metacarpals, a distinctive and diagnostically useful skeletal finding; in the nervous system HDAC4 regulates synaptic plasticity and memory consolidation through MEF2-dependent transcription of synaptic genes, and HDAC4 haploinsufficiency disrupts the normal balance of excitatory synapse pruning and stabilization that underlies learning and memory; the clinical phenotype of BDMR encompasses: (1) Brachydactyly — short 4th and 5th metacarpals (brachymetaphalangia), short and broad hands; (2) Intellectual disability — mild to moderate; (3) Obesity — common and clinically important for metabolic risk; (4) Behavioral features — autism spectrum disorder traits, ADHD, emotional dysregulation, and aggressive behavior; (5) Short stature; (6) Characteristic facial features; (7) Sleep disturbances; the 2q37 deletion form may include genes beyond HDAC4 — notably DYRK1B, TRPM7, and others — whose haploinsufficiency adds phenotypic features and whose clinical characterization requires documentation of the deletion boundary in each affected individual.
BDMR technology platforms — encompassing the molecular genetics laboratories where HDAC4 sequencing and chromosomal microarray analysis characterize the molecular basis and deletion boundary, the hand and foot skeletal monitoring platforms where X-rays document 4th and 5th metacarpal shortening and orthopedic or adaptive equipment needs are tracked, the weight and metabolic monitoring platforms where obesity risk, BMI trajectory, fasting metabolic panels, blood pressure, and metabolic syndrome markers are longitudinally tracked given the high prevalence of obesity in BDMR, the behavioral health and ABA platforms managing autism traits, ADHD, aggression, and emotional dysregulation across home, school, and community settings, the sleep monitoring and sleep study platforms addressing sleep disturbances that significantly affect quality of life for BDMR individuals and families, the developmental pediatrics and IEP coordination platforms organizing speech therapy, occupational therapy, physical therapy, and cognitive testing records, the growth and nutrition monitoring platforms tracking short stature and nutritional adequacy, the endocrine monitoring platforms managing metabolic syndrome risk from age 10, the ophthalmological surveillance platforms, and the rare disease registry platforms — must maintain availability and performance standards required by the obesity management urgency, skeletal surveillance obligations, behavioral management complexity, and sleep disorder monitoring requirements that define modern BDMR care coordination. This guide explains why BDMR tech platforms need dedicated monitoring, what components to monitor, and how to build a monitoring strategy matched to the obesity management urgency, skeletal monitoring obligations, behavioral complexity, and 2q37 deletion characterization requirements of HDAC4 Brachydactyly-Mental Retardation syndrome.
Why BDMR Tech Platforms Require Specialized Monitoring Attention
BDMR management is defined by several clinically important platform requirements: the obesity management urgency — with obesity being common, clinically significant, and a driver of metabolic syndrome, cardiovascular risk, and sleep apnea in BDMR, weight and metabolic monitoring platforms must support continuous BMI tracking, monthly weight reviews, and timely metabolic panel access; the skeletal surveillance obligation — with brachydactyly representing the pathognomonic skeletal finding and having functional implications for grip strength and hand function, skeletal monitoring platforms must track the natural history of metacarpal shortening, orthopedic management decisions, and adaptive equipment needs; the behavioral management complexity — with ADHD, autism traits, aggression, and emotional dysregulation requiring coordinated multi-setting interventions, behavioral documentation platforms must be continuously accessible to all members of the care team; the sleep disorder monitoring priority — with sleep disturbances being a significant quality-of-life burden in BDMR and obesity increasing the risk of obstructive sleep apnea, sleep monitoring platforms must support diary-based tracking and integration with overnight oximetry and polysomnography results; the 2q37 deletion boundary documentation requirement — with deletion size and gene content determining whether features beyond HDAC4 haploinsufficiency require additional surveillance, the molecular record platform must document the deletion boundary with precision.
HDAC4/2q37 molecular genetic testing platforms are the diagnostic cornerstone of BDMR. Chromosomal microarray identifies 2q37 deletions with deletion boundary characterization, while HDAC4 sequencing identifies intragenic mutations; both determine the molecular class with implications for additional gene content surveillance. Monitor molecular testing platforms at 1-minute intervals during laboratory hours.
Weight and metabolic monitoring platforms must support the obesity management urgency. Monthly BMI tracking, annual metabolic panels, and blood pressure surveillance are the primary metabolic safety metrics in BDMR. Monitor metabolic platforms at 1-minute intervals during clinical hours.
Behavioral documentation platforms coordinate multi-setting management. ABA, ADHD pharmacotherapy, aggression management protocols, and school accommodation plans all depend on consistent behavioral documentation. Monitor behavioral platforms at 1-minute intervals during clinical hours.
Sleep monitoring platforms address a significant quality-of-life burden. Sleep diaries, overnight oximetry, and CPAP management records all require reliable access. Monitor sleep platforms at 1-minute intervals during clinical hours.
What to Monitor on a BDMR Tech Platform
Molecular Genetic Testing — HDAC4 and 2q37 Deletion Characterization
Monitor HDAC4 molecular testing referral records (clinical suspicion documentation — brachydactyly, intellectual disability, obesity, ASD traits; test indication; chromosomal microarray plus HDAC4 sequencing order), chromosomal microarray analysis records (2q37 deletion detection — deletion size characterization; gene content documentation — which genes beyond HDAC4 are included; DYRK1B, TRPM7, and neighboring gene haploinsufficiency assessment; de novo vs. inherited status; deletion breakpoints), HDAC4 sequencing records (full coding sequence for intragenic loss-of-function mutations — nonsense, frameshift, splice site, missense; de novo confirmation), 2q37 vs. HDAC4-only distinction records (explicit molecular documentation of whether this is an isolated HDAC4 intragenic mutation or a 2q37 chromosomal deletion — with the deletion boundary size documented; clinical implications of additional gene haploinsufficiency noted), parental testing records (chromosomal microarray and HDAC4 sequencing in parents to confirm de novo status), and genetic counseling records (recurrence risk; prenatal testing options; family implications) at 1-minute intervals during laboratory hours. Alert immediately — HDAC4/2q37 molecular testing platform failures during the evaluation of a 3-year-old with short 4th and 5th metacarpals, mild developmental delay, and obesity delay the molecular confirmation that establishes BDMR, characterizes the deletion boundary, and determines the surveillance protocol for additional gene haploinsufficiency in the 2q37 region.
Hand and Foot Skeletal Monitoring
Monitor hand X-ray records (X-ray of hands at diagnosis — 4th and 5th metacarpal length measurement; brachymetaphalangia documentation; serial X-rays at 2-year intervals through skeletal maturity to track natural history), orthopedic consultation records (annual orthopedic review of hand function — grip strength testing; pinch strength; functional impact of metacarpal shortening; adaptive equipment trial — pencil grips, enlarged handles, keyboard accommodations), podiatry review records (foot X-ray at diagnosis — brachymetaphalangia of 4th and 5th metatarsals if present; pes planus assessment; orthotic prescription; shoe modification), hand function and adaptive equipment records (occupational therapy assessment of functional grip; adaptive equipment fitting; school and workplace accommodation documentation), and joint range of motion records (finger joint range of motion; joint laxity or stiffness documentation; impact on daily activities) at 1-minute intervals during clinical hours. Alert immediately — skeletal monitoring platform failures during the annual orthopedic review of a 12-year-old BDMR adolescent — when the orthopedic surgeon must compare current hand X-rays with the prior series to assess interval change in metacarpal development and update the adaptive equipment prescription for school activities — prevent the clinician from accessing the longitudinal imaging record required to guide safe and functional management.
Weight, BMI, and Metabolic Monitoring
Monitor weight and BMI records (CRITICAL — BMI at every clinical visit with monthly review recommended given the high obesity prevalence in BDMR; plotted on age-specific percentile charts; obesity alert threshold at BMI >95th percentile for age; obesity trend documentation; waist circumference as metabolic risk marker), dietary assessment records (dietary counseling session documentation; caloric intake assessment; food diary; registered dietitian referral records; caloric restriction guidance for obesity management), metabolic risk monitoring records (fasting glucose and HbA1c annually from age 10 in all BDMR individuals regardless of BMI, due to high obesity prevalence; fasting lipid panel annually from age 10; fasting insulin for insulin resistance assessment; blood pressure at every visit — CRITICAL given metabolic syndrome risk), physical activity records (physical activity log; adapted physical education referral; activity barriers from brachydactyly documented; activity-weight interaction monitoring), metabolic syndrome tracking records (waist circumference; triglyceride-to-HDL ratio; early metabolic syndrome recognition and intervention), and sleep apnea risk assessment records (obesity-related obstructive sleep apnea screening — overnight oximetry; CPAP prescription and adherence documentation; weight-sleep interaction) at 1-minute intervals during clinical hours. Alert immediately — metabolic monitoring platform failures during the annual metabolic panel review of a 14-year-old BDMR adolescent with a BMI in the 97th percentile — when the endocrinologist must access fasting glucose, HbA1c, lipid panel, and blood pressure trend records to determine whether pre-diabetes criteria are met and whether pharmacological intervention is warranted — prevent a timely metabolic intervention in a syndrome where obesity-related complications compound the neurodevelopmental burden.
Behavioral Management Diary and Coordination
Monitor behavioral management diary records (behavioral log across home, school, and therapy settings — autism trait documentation, ADHD symptom tracking, aggression episodes with precipitant and intensity, emotional dysregulation events, self-injurious behavior; caregiver-rated scales), ABA therapy records (ABA program goals; session frequency; behavior intervention plan; functional behavior assessment; aggression management protocols; crisis de-escalation procedures), ADHD management records (stimulant or non-stimulant medication; dose titration; side effect monitoring; Conners or Vanderbilt rating scale at each adjustment; cardiac baseline ECG before stimulant initiation), emotional dysregulation management records (co-occurring anxiety or mood disorder assessment; CBT or DBT-adapted approaches; psychiatry consultation documentation; medication management if indicated), school accommodation plan records (IEP behavioral support plan; one-to-one aide documentation; sensory accommodation; crisis protocol; teacher-therapist communication log), and multi-disciplinary behavioral coordination records (team meeting notes; consistency of behavioral strategies across settings; parent training documentation) at 1-minute intervals during clinical hours.
Sleep Monitoring
Monitor sleep diary records (caregiver sleep diary — sleep latency, night awakenings, parasomnias, early morning waking, daytime hypersomnolence; behavioral insomnia documentation; sleep hygiene review), sleep apnea risk assessment records (overnight oximetry for all BDMR individuals with obesity — desaturation events; AHI if polysomnography performed; CPAP initiation if OSA diagnosed; CPAP adherence and mask fitting documentation), melatonin management records (melatonin dose, timing, and formulation; response documentation; dose adjustment), and polysomnography records (full polysomnography if clinical sleep apnea suspected — AHI; sleep architecture; arousal index; respiratory event log; treatment escalation) at 1-minute intervals during clinical hours. Alert immediately — sleep monitoring platform failures during the follow-up visit for a 15-year-old BDMR adolescent with obesity and clinically suspected obstructive sleep apnea — when the pulmonologist must access the overnight oximetry trend, prior polysomnography report, and CPAP adherence data to determine whether current therapy is achieving adequate apnea control — prevent a clinical assessment that is essential for managing a sleep disorder that further impairs the cognitive and behavioral function of an individual already challenged by intellectual disability.
Developmental Records and IEP Coordination
Monitor developmental assessment records (cognitive testing every 2 years; Bayley, WPPSI, WISC, Leiter; adaptive function — Vineland; IQ documentation; adaptive skills trajectory), IEP and educational records (current IEP goals; school placement; related services — speech-language therapy, OT, PT; annual review; transition planning for adolescents), speech-language therapy records (expressive and receptive language evaluation; speech intelligibility; AAC evaluation and device records; therapy session logs), occupational therapy records (fine motor function; adaptive function; grip and pinch strength in the context of brachydactyly; adaptive equipment; activities of daily living), physical therapy records (gross motor skills; hypotonia management; activity participation in the context of obesity; short stature management), and transition to adult services records (adult intellectual disability services; vocational assessment; supported employment) at 1-minute intervals during clinical hours.
Growth Monitoring
Monitor growth parameter records (height at every visit — short stature documentation; height percentile tracking; growth velocity monitoring), nutritional status records (dietitian assessment; nutritional adequacy review; failure to thrive vs. obesity paradox in BDMR), and growth hormone evaluation records (growth hormone stimulation test if height falls below -2.5 SD and growth velocity is inadequate; IGF-1 and IGFBP-3 baseline; endocrinology referral documentation) at 1-minute intervals during clinical hours.
Endocrine Monitoring
Monitor endocrine panel records (annual fasting insulin; fasting glucose; HbA1c from age 10; lipid panel — LDL, HDL, triglycerides; blood pressure; thyroid function if clinically indicated), metabolic syndrome criteria documentation (WHO or IDF criteria tracking; treatment escalation documentation), and endocrinology consultation records (referral criteria; specialist recommendations; pharmacological intervention documentation — metformin, statin, antihypertensive as indicated) at 1-minute intervals during clinical hours.
Ophthalmological Monitoring
Monitor ophthalmological examination records (annual eye examination — refractive error; strabismus; amblyopia; optic disc assessment) at 1-minute intervals during clinical hours.
Authentication and Clinical Identity
Monitor authentication at 1-minute intervals, 24/7. BDMR management coordinates across molecular genetics (HDAC4/2q37 diagnosis), orthopedics (brachydactyly), endocrinology (obesity, metabolic syndrome), behavioral health (ABA, ADHD, aggression), sleep medicine (OSA), developmental pediatrics (IEP, cognitive assessment), speech-language pathology, occupational therapy, physical therapy, dietetics, and rare disease registry — authentication failures block every team member required to coordinate care across BDMR's multi-system phenotype.
SSL Certificates
Monitor SSL certificate expiry across all HDAC4/2q37 molecular testing platforms, skeletal monitoring systems, metabolic surveillance portals, behavioral documentation systems, sleep monitoring platforms, and rare disease registry platforms. Certificate errors can block BMI tracking access and behavioral diary access during clinical encounters.
HIPAA and Patient Privacy Considerations for BDMR
BDMR technology platforms handle PHI for children and adolescents with intellectual disability, most of whom require parent or legal guardian as HIPAA-authorized personal representative. As BDMR individuals reach legal adulthood, guardianship documentation or supported decision-making agreements must be maintained and verified across all care coordination platforms.
The behavioral documentation — ABA session records, aggression incident logs, ADHD medication records, and crisis documentation — is sensitive PHI requiring role-based access controls. The 2q37 deletion molecular records and HDAC4 variant documentation constitute genetic information subject to GINA and applicable state genetic privacy protections, requiring the highest level of access controls.
Alerting Strategy for BDMR Tech Platforms
Immediate clinical-hours alerting for HDAC4/2q37 molecular testing platforms: Gene sequencing, chromosomal microarray, deletion boundary characterization, and de novo confirmation.
Immediate clinical-hours alerting for weight and metabolic monitoring platforms: BMI tracking, fasting glucose, HbA1c, lipid panel, and blood pressure — CRITICAL given the high prevalence of obesity and metabolic syndrome.
Immediate clinical-hours alerting for skeletal monitoring platforms: Hand X-rays, orthopedic consultation, and adaptive equipment coordination.
Immediate clinical-hours alerting for behavioral management platforms: ABA diary, ADHD management, aggression incident log, and crisis de-escalation protocol.
Immediate clinical-hours alerting for sleep monitoring platforms: Sleep diary, overnight oximetry, CPAP adherence, and polysomnography results.
Sustained-failure alert (10–15 minutes): Developmental records, IEP coordination, speech-language therapy, growth monitoring, and rare disease registry platforms.
30-day advance warning: SSL certificates across all domains.
Vigilmon's multi-region monitoring confirms BDMR platform availability from the geographic regions where HDAC4/2q37 molecular testing centers, metabolic syndrome clinics, orthopedic programs, and neurodevelopmental pediatric services operate.
Status Page for BDMR Care Team Communication
A real-time status page gives molecular genetics laboratory directors confirming HDAC4 variants and 2q37 deletion boundaries, endocrinologists managing obesity and metabolic syndrome, orthopedic surgeons tracking brachydactyly, behavioral health teams coordinating ABA and aggression management, sleep medicine specialists managing sleep apnea, and rare disease coordinators enrolling patients in BDMR registries immediate platform visibility without requiring inbound IT support contact.
Include the status page URL in HDAC4 laboratory backup procedures, metabolic clinic downtime contingency plans, and behavioral emergency workflows.
Vigilmon Setup for BDMR Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication | 1 min | Slack + PagerDuty (24/7) | | HDAC4 sequencing (intragenic mutations) | 1 min | Slack + PagerDuty (lab hours) | | 2q37 chromosomal microarray (deletion detection) | 1 min | Slack + PagerDuty (lab hours) | | 2q37 deletion boundary and gene content documentation | 1 min | Slack + PagerDuty (lab hours) | | Weight and BMI monitoring (monthly) | 1 min | Slack + PagerDuty (clinical hours) | | Fasting glucose, HbA1c, lipids, blood pressure | 1 min | Slack + PagerDuty (clinical hours) | | Metabolic syndrome tracking and endocrinology | 1 min | Slack + PagerDuty (clinical hours) | | Hand X-ray and skeletal monitoring | 1 min | Slack + PagerDuty (clinical hours) | | Orthopedic consultation and adaptive equipment | 1 min | Slack + PagerDuty (clinical hours) | | Behavioral management diary (ABA, ADHD, aggression) | 1 min | Slack + PagerDuty (clinical hours) | | Crisis de-escalation and school accommodation | 1 min | Slack + PagerDuty (clinical hours) | | Sleep diary and overnight oximetry | 1 min | Slack + PagerDuty (clinical hours) | | CPAP management and sleep apnea follow-up | 1 min | Slack + PagerDuty (clinical hours) | | Growth monitoring (height, short stature) | 2 min | Slack (clinical hours) | | Speech-language therapy and AAC records | 2 min | Slack (clinical hours) | | Developmental assessment and IEP coordination | 2 min | Slack (clinical hours) | | Ophthalmological monitoring | 2 min | Slack (clinical hours) | | Rare disease registry and natural history study | 2 min | Slack (business hours) | | SSL: all domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add authentication endpoints at 1-minute intervals with 24/7 alerting
- Configure weight and BMI monitoring platforms with immediate clinical-hours alerting — CRITICAL given the high obesity prevalence
- Add fasting metabolic panel platforms (glucose, HbA1c, lipids, blood pressure) with immediate clinical-hours alerting
- Configure metabolic syndrome tracking and endocrinology platforms with immediate clinical-hours alerting
- Add HDAC4 sequencing platforms with immediate laboratory-hours alerting
- Configure 2q37 chromosomal microarray platforms with immediate laboratory-hours alerting
- Add 2q37 deletion boundary documentation platforms with immediate laboratory-hours alerting
- Configure hand X-ray and skeletal monitoring platforms with immediate clinical-hours alerting
- Add orthopedic consultation and adaptive equipment records with immediate clinical-hours alerting
- Configure behavioral management diary platforms with immediate clinical-hours alerting
- Add crisis de-escalation and school accommodation platforms with immediate clinical-hours alerting
- Configure sleep diary and overnight oximetry platforms with immediate clinical-hours alerting
- Add CPAP management and sleep apnea follow-up platforms with immediate clinical-hours alerting
- Configure growth monitoring platforms with sustained-failure alerting
- Add speech-language therapy and AAC record platforms with sustained-failure alerting
- Configure developmental assessment and IEP coordination with sustained-failure alerting
- Add ophthalmological monitoring platforms with sustained-failure alerting
- Configure rare disease registry platforms with sustained-failure alerting during business hours
- Enable SSL certificate monitoring across all molecular testing, metabolic, skeletal, and behavioral platforms
- Add the status page URL to HDAC4 laboratory backup procedures and metabolic clinic downtime contingency plans
Conclusion
BDMR technology platforms are embedded in clinical decisions where metabolic monitoring platform availability during the annual metabolic review of a 16-year-old BDMR adolescent with a BMI in the 98th percentile and a family history of type 2 diabetes — when the endocrinologist must access the fasting glucose trend, prior HbA1c values, lipid panel history, and blood pressure trajectory to determine whether pre-diabetes criteria are met and whether metformin initiation is warranted to reduce the risk of overt diabetes in an individual whose neurodevelopmental disability will make self-management of diabetes substantially more challenging — cannot be disrupted by metabolic records platform failures that prevent access to the longitudinal metabolic data that is the clinical foundation of every obesity-related intervention decision in BDMR; where skeletal monitoring platform availability during the orthopedic review of a 10-year-old BDMR child complaining of hand fatigue and difficulty with handwriting — when the orthopedic surgeon must access the serial hand X-ray records documenting 4th and 5th metacarpal shortening and the prior occupational therapy evaluation to determine whether the functional limitations have progressed and whether an updated adaptive equipment prescription is needed for school — cannot be disrupted by skeletal records platform failures that prevent access to the longitudinal imaging comparison that drives the management decision; and where sleep monitoring platform availability during the follow-up assessment of a BDMR adolescent whose parents report snoring, witnessed apnea, and morning headaches — when the sleep medicine specialist must access the prior overnight oximetry records and the CPAP adherence log to determine whether current CPAP settings are achieving adequate apnea control or whether pressure titration is needed — cannot be disrupted by sleep records platform failures that deny access to the monitoring data whose clinical value lies precisely in tracking the treatment response of a sleep disorder that compounds the cognitive and behavioral burden of intellectual disability. An HDAC4 molecular testing platform unavailable when a clinician needs the deletion boundary result to determine whether DYRK1B haploinsufficiency adds features requiring additional surveillance, a metabolic monitoring platform down when an endocrinologist must act on a borderline HbA1c in an obese adolescent with intellectual disability, a behavioral diary platform inaccessible when an ABA team must review the aggression incident log to update a safety plan for a child in crisis — these are not IT incidents. They are clinical disruptions in the management of a syndrome whose obesity burden, skeletal distinctiveness, behavioral complexity, and sleep disorder prevalence demand continuous, coordinated, and documented care across multiple specialties.
Uptime monitoring gives BDMR tech teams the detection capability to identify failures within seconds, trigger immediate clinical downtime procedures, and demonstrate to HDAC4/2q37 molecular testing laboratories, metabolic and endocrinology clinics, orthopedic programs, behavioral health services, and compliance auditors that platform operational reliability matches the obesity management urgency, skeletal surveillance obligations, behavioral management complexity, and sleep disorder monitoring requirements of modern HDAC4 Brachydactyly-Mental Retardation syndrome care.
Start monitoring your BDMR care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #BDMR #HDAC4 #brachydactyly #2q37deletion #histonedeacetylase #classIIa #RUNX2 #MEF2 #brachymetaphalangia #intellectualdisability #neurodevelopmental #obesity #metabolicsyndrome #sleepapnea #ASD #ADHD #raredisease #HIPAA #healthtech #digitalhealth #uptime #sre